D-0630-2020 Class I Terminated

Recalled by Lannett Company, Inc. — Philadelphia, PA

FDA drug recall D-0630-2020 was initiated by Lannett Company, Inc. on Dec 6, 2019 and is designated Class I. Reason for recall: Microbial Contamination of Non-sterile Products: Out-of-specification results obtained for Total Aerobic Microbial Count. The recall status is terminated (terminated Jul 13, 2020). Affected quantity: 16,668 bottles.

Recall details

Product Type
Drugs
Report Date
Dec 25, 2019
Initiation Date
Dec 6, 2019
Termination Date
Jul 13, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
16,668 bottles

Product description

Levetiracetam Oral Solution 100mg/mL, 473 mL (16 fl. oz.) Bottles, Rx Only, Distributed by: Lannett Company, Inc. Philadelphia, PA 19136, NDC 54838-0548-80

Reason for recall

Microbial Contamination of Non-sterile Products: Out-of-specification results obtained for Total Aerobic Microbial Count.

Distribution pattern

Nationwide within the United States

Code information

Lot #: 2190A, 2191A, Exp. Date 07/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0630-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0630-2020. Report a data issue: hello@regdatalab.com.